See the Interactions section for more details
Observational and real-world data Published case series are limited, but the pharmacokinetic modeling from Kapitza et al
Laboratory biomarkers Blood testing provides clinical-grade assessment of metabolic status
doi: 10.1093/nar/gkae973 Summary Keywords atheroscelrosis, cholesterol metabolism, acetyl-L-carnitine (ALC), SREBP2, HMGCR Citation Xing J, Du Z, Li F, Wang Y, Zhang Z, Gao X, Han L, Sun X, Sun H, Du Y, Hu C, Yu H and Qin Y (2024) Acetyl-L-carnitine ameliorates atherosclerosis in LDLR / mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis
If nausea is severe or persistent, temporary dose reduction or slower dose titration may be necessary